Ariad Pharmaceuticals Inc fka ARIA

[iandy]

>.. they made the deal with Merck on the least promising drug in their pipeline.. this allows them all of the above to get Pron, and 113 to market<

I do not profess to be an expert on biotech financing but I do not see how they could bring pron and 113 to market based on the proceeds from anticipated rida sales.

Once we get the anticipated pona results the potential size of the market for pron will be better known and they can get a better deal (with less impact on the share price), no matter what form of financing they decide on.

I do not think they could be strapped for cash this year.